SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001989984-23-000001
Filing Date
2023-08-15
Accepted
2023-08-15 15:25:55
Documents
1
Effectiveness Date
2023-08-15
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 5805
  Complete submission text file 0001989984-23-000001.txt   6900
Mailing Address 535 W. RESEARCH CENTER BLVD SUITE 135 FAYETTEVILLE AR 72701
Business Address 535 W. RESEARCH CENTER BLVD SUITE 135 FAYETTEVILLE AR 72701 479-571-2592
VIN-41 Neurexis Therapeutics, LLC (Filer) CIK: 0001989984 (see all company filings)

IRS No.: 932143409 | State of Incorp.: AR | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-489806 | Film No.: 231174635